NCT00299598|Completed
Clinical Study of Antibacterial Nanoparticles Incorporated in Composite Restorations
phase2 Safety and Efficacy of Antibacterial Nano Particles Incorporated in Dental Composite.
Loading search results
phase2 Safety and Efficacy of Antibacterial Nano Particles Incorporated in Dental Composite.
Sponsor study identifier
observational
10
1 country
1
Study Start
September 2006
Date type not reportedThis date has not been verified as actual or estimated.
Primary Completion
December 2009
Actual (reported)Study Completion
December 2009
Actual (reported)Resin composites withholding antibacterial properties may be useful in preventing recurrent caries. Covalently attached antibacterial polymers are a possible solution.This in vivo study would evaluated the antibacterial effect of alkylated polyethylenimine nanoparticles incorporated into flowable and hybrid composite resin disks embedded in a palatal removable appliance.The disks would be in close contact with the palate in order to check for contact mucosities. disks on the side facing the Tongue would be evaluated for their antibacterial potency with confocal laser scanning microscopy.
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
December 2009
Actual (reported)Click on a node to explore related trials.
Some registry-reported names shown below are not yet linked in this graph.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
March 5, 2006
Actual (reported)March 7, 2006
Actual (reported)September 2006
Date type not reportedThis date has not been verified as actual or estimated.
December 2009
Actual (reported)December 2009
Actual (reported)Registry-reported names are shown in full. Names without a link have not yet been matched to a Syfrah profile.
personal of Hadassah MO
Hadassah Medical Organization
Jerusalem, 91120, Israel
Matalon S, Slutzky H, Weiss EI. Surface antibacterial properties of packable resin composites: part I. Quintessence Int. 2004 Mar;35(3):189-93.
Ervin I Weiss, DMD
Hadassah Medical Organization
Avi Domb, Phd
Hebrew University of Jerusalem
Michael M Perez Davidi, DMD
Hadssah Medical Orgenization
Nurit Beyth, DMD
Hadassah Medical Organization
10 participants (actual enrollment reported by the registry).
First Submitted
March 5, 2006
First Posted
March 7, 2006
Study Start
September 2006
Date type not reportedThis date has not been verified as actual or estimated.
Streptococcus Dentisani Colonization Capacity in a Split Mouth Model
Contact the study team to confirm eligibility.
Primary Completion
December 2009
Actual (reported)Study Completion
December 2009
Actual (reported)Last Updated
January 6, 2010
Record last verified: 2009-10
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved: